Talk:Linezolid/GA1

Latest comment: 8 years ago by Oirudleahcim in topic GA Review

GA Review edit

Article (edit | visual edit | history) · Article talk (edit | history) · Watch

Comments to follow soon jimfbleak (talk) 12:02, 19 May 2009 (UTC)Reply

  • images all OK, query "click to enlarge" on two images, since thumbed anyway
    • I considered forcing a larger image size, but didn't think it would be a good idea. Perhaps get rid of the "invitation"?
      • Yes, the thumb symbol is self-explanatory, and people don't like forced image sizes because it overrides settings jimfbleak (talk) 14:22, 19 May 2009 (UTC)Reply
  • references first quick scan of refs - seem reliable and consistently and correctly formatted. It would be good practice to write the journal names in full (required if you go to FAC).
    • Hmm, didn't know that was a requirement now. Easy fix, though I personally prefer abbreviations. Done. Fvasconcellos (t·c) 14:33, 19 May 2009 (UTC)Reply
  • several thousands of dollars suggest several thousand US dollars (unless you mean Canadian)
  • some padding however for instance and similar sprinkled throughout
    • That's a terrible habit of mine. Please feel free to remove any you find unnecessary—I'll have a go at it myself.
  • MIC90 - would it be better to spell out this - a casual reader has no chance of knowing the abbreviation?
    • OK. I thought the link would be sufficient, but we shouldn't presume readers will click on them :)
      • I think it's good practice, as you have done elsewhere, to spelll out abbreviations first time (even if there is a link jimfbleak (talk) 14:22, 19 May 2009 (UTC)Reply
  • There is no mention of use or approval outside the UK and N America. Whilst I wouldn't want this to become a list, and I appreciate the difficulty of working with non-English sources, it looks a bit Anglo-centric. Not a deal breaker, but anything else would help to round it out - is it widely used in the EU or Japan for example?
    • Will try to expand on this later.
      • Fine jimfbleak (talk) 14:22, 19 May 2009 (UTC)Reply
        • OK, I've expanded on approval. It's not easy to find top-notch sources for approval dates, though. Fvasconcellos (t·c) 14:33, 19 May 2009 (UTC)Reply

You obviously know what you are doing, I'll give you a while to respond before a final read and formal assessment jimfbleak (talk) 12:43, 19 May 2009 (UTC)Reply

Thanks. Please feel free to list anything else you think could or should be improved. Best, Fvasconcellos (t·c) 13:29, 19 May 2009 (UTC)Reply

Review edit

  1. It is reasonably well written.
    a (prose):   b (MoS):  
  2. It is factually accurate and verifiable.
    a (references):   b (citations to reliable sources):   c (OR):  
  3. It is broad in its coverage.
    a (major aspects):   b (focused):  
  4. It follows the neutral point of view policy.
    Fair representation without bias:  
  5. It is stable.
    No edit wars etc.:  
  6. It is illustrated by images, where possible and appropriate.
    a (images are tagged and non-free images have fair use rationales):   b (appropriate use with suitable captions):  
  7. Overall:
    Pass/Fail:  

I wish they were all this easy! jimfbleak (talk) 14:47, 19 May 2009 (UTC)Reply

Thank you! I didn't think it would be this easy either :) Fvasconcellos (t·c) 15:42, 19 May 2009 (UTC)Reply

What does the paragraph starting with "In 2009, Pfizer paid $2.3 billion and entered a corporate integrity agreement to settle charges that it had misbranded and illegally promoted four drugs, and caused false claims to be submitted to government healthcare programs. . ." have to do with linezolid? NOTHING. It's editorializing. — Preceding unsigned comment added by Oirudleahcim (talkcontribs) 02:12, 25 October 2015 (UTC)Reply